S Wu, T Luo, X Lei, X Yang - Journal of Chemotherapy, 2024 - Taylor & Francis
Lung cancer remains one of the most common malignant cancers worldwide, and its survival
rate is extremely low. Chemotherapy, the mainstay of lung cancer treatment, is not as …